Log In
BCIQ
Print this Print this
 

NNC9204-0530

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionUndisclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today